The “deep state” is said to be investigating the mysterious discovery of “questionable vials” labeled “smallpox” that were found in a freezer at a Merck facility just outside of Philadelphia. An unclassified “For Official Use Only” alert sent to Department of Homeland Security (DHS) leadership explained that the Federal Bureau of Investigation (FBI) and the Centers for … Continue reading Could Merck unleash a SMALLPOX pandemic to strip mine even more plague profits off the American people?
In the latest episode of the Moderna pump-and-dump show, company chairman Noubar Afeyan has announced that everyone will need to get endless “booster” shots of Moderna’s mRNA “vaccine” in order to stay protected. Speaking to Fox Business host Maria Bartiromo, Afeyan revealed that the “fully vaccinated” may end up needing an “annual booster” of spike proteins, “potentially varying on … Continue reading YOU are the business model: Moderna says never-ending “booster” shots needed to eliminate covid
Thanks to Donald Trump’s “Operation Warp Speed” scheme, drug giant Moderna is slated to rake in record profits this year with a revenue forecast of a whopping $19.2 billion. Tony Fauci also contributed by laundering gobs of taxpayer cash to Moderna through his National Institute of Allergy and Infectious Diseases (NIAID), which also received $25 million from the Defense Advanced … Continue reading Big Pharma cashing in on the plandemic: $19 BILLION for Moderna in just one year
The coronavirus (COVID-19) pandemic has created nine new billionaires from the pharmaceutical industry. Campaigners from the People’s Vaccine Alliance, whose members include Global Justice Now, Oxfam and UNAIDS, have analyzed Forbes Rich List data to highlight the massive wealth being generated for a handful of people from vaccines which were largely publicly funded. Moderna CEO Stéphane Bancel … Continue reading Coronavirus pandemic creates 9 new Big Pharma billionaires
Remdesivir, the wonder drug touted to treat the Wuhan coronavirus (COVID-19), showed a “limited benefit” in a large trial involving patients exhibiting moderate symptoms. Gilead Sciences released the initial findings of its phase 3 trial Tuesday, saying that remdesivir “improved clinical outcomes by several different measures,” in a statement. A phase 3 trial involves testing the drug on a large number of … Continue reading Remdesivir shows “limited benefit” during trial, so why did the FDA approve it?